Hong Kong-based technology firm Lenovo Group will build a $26.3 million manufacturing facility in Hungary create 1,000 jobs and introduce advanced technological solutions, says the country's Minister of Foreign Affairs and Trade Peter Szijjarto.
The investment was supported by a $6.4 million Hungarian government grant.
The plant, which will rise in Ullo on the outskirts of Budapest, could start producing desktops, data center products, and workstations by early 2021.
The minister noted that the investment would accelerate industrial production and offer great opportunities for Hungary's economy and its engineers.
Szijjarto stressed that investment confirmed that leading technology companies trusted Hungary.
He added that global competition for Lenovo's investment was fierce.
Lenovo's presence in Hungary is currently based solely on trade, utilizing a workforce of 80.


Google Secures Pentagon AI Deal for Classified Projects
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



